Come up with a name for your new list and we'll add to it:
Hengrui Therapeutics raised a round of funding on June 23, 2016. Investors include
HR Bio Holdings.
Hengrui Therapeutics is a recently formed biopharmaceutical company engaged in the development and commercialization of innovative cancer therapies. The company's drug pipeline consists of multiple cl…